logo
I was 20 minutes from death after an 'invisible illness' ravaged my body - I thought my life was over but now I'm GLAD it happened, reveals Tom Speight

I was 20 minutes from death after an 'invisible illness' ravaged my body - I thought my life was over but now I'm GLAD it happened, reveals Tom Speight

Daily Mail​12 hours ago
Tom Speight was 20 minutes from death and thought that his life was over after his 'invisible illness' ravaged his body - but has admitted that he's now glad it happened.
The 38-year-old singer, who was diagnosed with Crohn's disease when he was 19, opened up about his journey with the condition to Cat Deeley, 48, and Ben Shephard, 50, on Tuesday's episode of This Morning.
'Crohn's disease is a long-term condition where part of your gut becomes inflamed. It cannot currently be cured,' according to the NHS.
Tom, who is an ambassador for Crohn's and Colitis UK, is due to take part in a charity challenge this weekend to raise awareness for the disease.
He explained: 'I've had Cronn's for 20 years which is crazy. It's been a roller coaster. I was thinking about it the other day, first time in two years, where I haven't been in hospital every year, I wrote largely most of my first album in hospital.
'To do this challenge, raising money for Crohn's and Colitis UK, I'm super proud.'
The 38-year-old, who was Crohn's disease when he was 19, opened up about his journey with the condition to Cat Deeley, 48, and Ben Shephard, 50, (pictured) on Tuesday's episode of This Morning
Recalling what happened when he was diagnosed, Tom said: 'It came out of nowhere, I was at university, I was having diarrhea, vomiting, weight loss.
'I didn't know anything about it.
'It's important, if I can speak about it. At the time, there wasn't much awareness of Crohn's, it's important we get the word out there.
'It's an invisible illness, as well.'
Ben pointed out how serious it is as he was 20 minutes away from death at one point.
Tom said: 'Yeah, that was four years after diagnosis. 20 minutes from dying, basically. yeah. Which sounds really dramatic. And then I woke up with a stoma.'
According to the NHS, 'a colostomy is where part of your large bowel (colon) is brought out through an opening made in your tummy. The opening is called a stoma.'
Ben asked: 'Coming to terms with that must have been really, really difficult.
'How old were you at the time?'
'I would have been 23/24,' Tom replied.
He continued: 'I had a record deal, publishing deal, I remember thinking at the time when they said that they were going to have to put me in surgery, I was more worried about all of that disappearing, than the actual surgery itself.
'I just thought it's over for me, I don't know any musicians that have these things.
'I didn't really speak about it until my third album, where I thought if I have a platform I can do it for my younger self and say "It's going to be alright".
'We've toured the world, I've got back from Brazil and Argentina, done Glastonbury, living the dream, on Radio 2.
'I'm here to say to people at home, if you're struggling to get out of bed today, you can do it, this idiot has signed up for an army challenge.'
They then touched upon him posing topless with his stoma.
Tom joked: 'Let's be honest, two days later, you [Ben] were on Men's Health... I was like some budget version of Ben Shephard for a couple of days.
'That was nerve wracking.
'I hadn't taken my top off ever, since surgery, I wear a support band.
'To be standing in front of a cameralense, was daunting really. I did it to own the disease and having a stoma.
'I recently became single in the last year, I kept on thinking it was a stumbling block of like having these conversations so now I'm just going to have it as my Tinder profile.'
He added: 'I think there is misconceptions, I started going to the gym and people working out with asking "can you do this, can you do that?"
'I didn't play football for like 10 years because I was worried about getting injured. This is why I want to do the challenge to say nothing will hold me back.
'Having stoma or Crohn's, it's like my super power, it gave me a whole lease of life.
'Since diagnosis to that surgery, I was just existing really. I'm thriving.'
This Morning airs weekdays from 10am on ITV.
CROHN'S DISEASE EXPLAINED
Crohn's disease is a long-term condition that causes inflammation of the lining of the digestive system.
Inflammation most commonly occurs in the last section of the small or large intestine but it can affect any part of the digestive system.
Common symptoms can include:
diarrhoea
abdominal pain
fatigue (extreme tiredness)
unintended weight loss
blood and mucus in your faeces (stools)
Remission occurs when people with the disease go long periods of time without symptoms however these periods can be followed by flare ups of symptoms.
Why it happens
The exact cause of Crohn's disease is unknown. However, research suggests a combination of factors may be responsible. These include:
genetics – genes you inherit from your parents may increase your risk of developing Crohn's disease
the immune system – the inflammation may be caused by a problem with the immune system that causes it to attack healthy bacteria in the gut
previous infection – a previous infection may trigger an abnormal response from the immune system
smoking – smokers with Crohn's disease usually have more severe symptoms than non-smokers
environmental factors – Crohn's disease is most common in westernised countries such as the UK, and least common in poorer parts of the world such as Africa, which suggests the environment has a part to play
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pupils with special needs ‘have to travel further to school for suitable place'
Pupils with special needs ‘have to travel further to school for suitable place'

The Independent

time30 minutes ago

  • The Independent

Pupils with special needs ‘have to travel further to school for suitable place'

Children with special educational needs are having to travel long distances to school due to a lack of suitable provision near home, councils have suggested. Budgets for home to school transport are under 'considerable pressure' as many special schools are full, which is forcing pupils to travel further, according to a Local Government Association (LGA) report. Spending by councils on transporting children and young people with special educational needs and disabilities (Send) to schools is predicted to reach around £1.97 billion in 2025/26, up from around £1.73 billion in 2023/24 and approximately £645 million in 2015/16. Children under eight are entitled to free home to school transport if the nearest suitable school is more than two miles away, or more than three miles for older children. The average one-way trip to school for pupils with Send is nine miles, according to the research carried out by the Isos Partnership, but one county council reported an average distance of 22.8 miles. Councils reported that a 'growing minority' of children and young people with Send are travelling very long distances to school – often due to a lack of suitable special school places closer to their home. The report warned that continuing to fulfil the current statutory responsibilities for home to school transport is becoming 'increasingly financially unsustainable' for local authorities. The findings have been published during the LGA's three-day annual conference in Liverpool this week. Schools minister Catherine McKinnell is due to address council leaders on the Send system at the LGA's conference on Wednesday morning. Department for Education (DfE) data last week showed that the number of education, health and care plans (EHCPs) – which set out the support a young person requires for their Send needs – has increased. In total, there were 638,745 EHCPs in place in January, up 10.8% on the same point last year. The LGA report said the rise in the number of children and young people who require education in a special setting has 'placed considerable pressure on home to school transport budgets as most special schools are full, forcing children to travel further distances to access a place that meets their needs'. Councils have reported a 40% rise over the last five years in children and young people with Send (aged under 16) needing home to school transport, the research suggested. Arooj Shah, who chairs the LGA's children and young people board, said: 'The rapidly rising need for home to school transport from children and young people in Send is yet another reminder of the huge pressures on the Send system. 'It is also wrong that children are increasingly having to travel long distances to get to school because of a lack of provision near to their home. 'This has to change. 'We urge the Government in its White Paper to deliver the comprehensive reforms the Send system needs, so that it is more inclusive and improves educational attainment for children. 'This should also include putting councils on a stable financial footing by writing off councils' high needs deficits, which are projected to reach £5 billion next year.' A DfE spokeswoman said: 'This Government inherited a Send system left on its knees – which is why we are looking at changes to enable more children to thrive in mainstream settings and stop parents having to fight for help, while bringing about financial sustainability for councils. 'Through our plan for change, we're already making progress by investing £740 million to create more places for children with Send in mainstream schools, as well as increasing early access to speech, language and neurodiversity support to prevent needs from escalating. 'This will pave the way for significant, long-term reform – improving children's and parents' experiences and addressing the pressures councils are facing, including around home to school transport.'

Terminal breast cancer patients denied life-extending drugs
Terminal breast cancer patients denied life-extending drugs

The Independent

timean hour ago

  • The Independent

Terminal breast cancer patients denied life-extending drugs

Thousands of women battling advanced breast cancer could be denied access to crucial life-extending medication due to an "unfair" assessment process for NHS drug approval. Charity Breast Cancer Now has issued an urgent plea to Health Secretary Wes Streeting, demanding "immediate action" to dismantle current spending restraints. The organisation is also calling for the NHS spending watchdog, the National Institute for Health and Care Excellence (Nice), to lower its threshold for what it classifies as a "very severe health condition." Nice's severity modifier, introduced in 2022, is designed to give greater weight to treatments for more severe illnesses, increasing the likelihood of their recommendation for NHS use. However, Breast Cancer Now argues that the current criteria are too stringent, potentially preventing thousands of women from accessing vital therapies. According to Nice, the process raises the threshold for what it considers to be a cost-effective treatment, meaning it can give more expensive drugs the green light. However, a new report from Breast Cancer Now claims the system means women with incurable breast cancer with months to live may be told their condition does not qualify for the most severe rating. The call comes after it emerged that the life-extending drug Enhertu will not be made available for women with incurable breast cancer on the NHS in England and Wales. In November, Nice said talks with manufacturers AstraZeneca and Daiichi Sankyo over the price of the medication had broken down for the third time with no agreement. Claire Rowney, chief executive at Breast Cancer Now, said: 'The terrifying reality is that unless urgent action is taken thousands of women in the UK with incurable secondary breast cancer could be denied access to vital life-extending treatments because of an unfair system. 'We're talking about patients missing out on access to cutting-edge, effective treatments that could give them more time to be there for special moments such as birthdays or seeing their children or grandchildren start school. 'Treatments, such as Enhertu, that patients in other countries, including Scotland, can access, giving them the chance to live longer. 'Women with secondary breast cancer tell us they feel their lives are being deprioritised by the changes to the system. 'We will not stand by and witness more drugs being rejected or not taken forward, when the devastating cost is thousands more people with secondary breast cancer across England, Wales and Northern Ireland having their lives cut short.' Paula Van Santen, 50, was diagnosed with secondary breast cancer in July 2022, two months after her diagnosis of primary breast cancer. The mother-of-three, from Banbury in Oxfordshire, said: 'Secondary breast cancer has changed the lives of both myself and my family beyond belief. Coming to terms with my diagnosis is the hardest part because I've had to grieve for the life I had, but also the life that I'm not going to have. 'If a new drug can give me another six months, if it gives me another year, it's worth it. 'It could allow me to see my daughter get to 21, see my children get married or meet grandchildren. Just to have a picture with a grandchild so they would know that I existed would be so precious. That's what this could give.' Main symptoms of breast cancer in women NHS Ms Rowney called for 'change' and said Mr Streeting should scrap 'opportunity-cost neutral' restraints. Opportunity cost neutrality in the Nice severity modifier aims to ensure the new system does not require more or less overall NHS funding than the old one. According to the Breast Cancer Now report, this is 'at the root of the issues with the modifier'. It added: 'It pits end-of-life cancer treatments against other severe conditions like cystic fibrosis in a way that's reductive and unfair to patients. And, ultimately, it creates barriers to the approval of drugs for advanced cancers.' Ms Rowney said: 'The system for deciding whether drugs are approved for use on the NHS must change now. 'We're calling for immediate action from Wes Streeting, Secretary of State for Health and Social Care, to urgently scrap 'opportunity-cost neutral' restraints and for Nice to lower the bar for what it defines as 'a severe condition'. And we stand ready to work with them.' Dr Samantha Roberts, chief executive of Nice, welcomed the report from Breast Cancer Now, saying: 'The independent analysis we commissioned recently showed the new severity weighting is working as intended and expected. 'It is able to be applied more widely – for example to treatments for cystic fibrosis, hepatitis D and Duchenne muscular dystrophy – and has contributed to an increase in positive decisions for cancer medicines and non-cancer medicines. 'And other breast cancer treatments have been recommended since we introduced the severity modifier – including for advanced breast cancer. 'We remain deeply disappointed that we were unable to recommend Enhertu for HER2-low advanced breast cancer. We know this was devastating to all those hoping for a different answer. 'It remains the only breast cancer treatment we have been unable to recommend in seven years.' A Department of Health and Social Care spokesperson said the upcoming 10-year health plan will 'transform the NHS and improve care for those facing cancer'. 'This includes rolling out DIY screening kits for cervical cancer, more radiotherapy machines in every region and opening more Community Diagnostic Centres closer to where people live,' they added. 'We know how disappointing it is to many families that the manufacturers of Enhertu are unwilling to sell this life-extending treatment to the NHS at a fair and reasonable price. Our door remains open to supporting the introduction of medicines at a cost-effective price.'

NHS to get technology fast lane to roll out new equipment more quickly after it passes trials
NHS to get technology fast lane to roll out new equipment more quickly after it passes trials

The Sun

timean hour ago

  • The Sun

NHS to get technology fast lane to roll out new equipment more quickly after it passes trials

THE NHS will get a technology fast lane to roll out new equipment more quickly after it passes trials. The 'innovator passport' is part of Health Secretary Wes Streeting 's bid to cut red tape and modernise the service. 1 He said: 'For too long, Britain 's leading scientific minds have been held back by needless admin. 'Suppliers are repeatedly asked for the same data in different formats by different trusts. 'These innovator passports will save time and reduce duplication, meaning our life sciences sector can work hand in hand with the health service and make Britain a powerhouse for medical technology." Under the new system, sign-off from one central office after a pilot trial will be enough for something to be funded and used nationwide. Examples of kit not yet being widely used despite successful trials include better wound dressings and rapid flu tests. Mr Streeting added 'Frustrated patients will no longer have to face a postcode lottery for lifesaving products.' Sam Roberts, chief of spending watchdog the National Institute of Health and Care Excellence, said: 'Access to life-changing technologies that address the most urgent needs will no longer be a case of a postcode lottery. 'Patients will get access wherever they live, the NHS will get better value by buying at scale, and we can stop relying on outdated tools that lead to poorer outcomes.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store